Contact our Head of Personalized Oncology Services.

As soon as you and your patient are ready to move forward, we will arrange for biopsies, usually from already collected tumor samples or previous biopsies, to be sent to CLIA-approved laboratories that run CollabRx ONE specified tests.

Our experts will then perform extensive genomic research and in-depth analysis of the molecular profile, in order to suggest therapy options that could address the mechanisms responsible for sustaining your patient’s illness. We will then present the results, and the scientific rationale, to you and your patient. Our goal is to provide information and context/further studies to help you adjust your patient’s treatment plan with the findings from the personalized research as appropriate.

Please contact us to learn more about CollabRx ONE personalized research services.